Accuracy results of repeated double cross validation of the Random Forest and Linear Discriminant Analysis (LDA) models built to classify patients with prostate cancer and cancer-free controls based on blood PSA levels and urinary VOCs. The gene discussed is KLK3; the disease is prostate cancer.